Fentanyl Citrate
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 7 | SUPPLYING |
| Hospira, Inc. | brand | 7 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lack of Assurance of Sterility; potential loose metal overseal crimp defects. — Recalling firm: Pfizer Inc. — United States including Puerto Rico
Lack of Assurance of Sterility; improperly crimped fliptop vials — Recalling firm: Hospira Inc. — Nationwide
Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing. — Recalling firm: Hospira Inc. — U.S. Nationwide
Fentanyl Citrate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Analgesia/Addiction, Pediatric.
Fentanyl Citrate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction, Pediatric.
